Literature DB >> 27056628

Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations.

Troii Hall1, Stephanie L Sandefur1, Christopher C Frye1, Tammy L Tuley1, Lihua Huang2.   

Abstract

Decreases in polysorbate (PS80) content were observed while evaluating the long-term storage stability of Chinese hamster ovary-derived, purified monoclonal antibodies. It was determined that polysorbate had been enzymatically degraded; therefore, studies were performed to identify and characterize the protein(s) responsible. Polysorbate degrading activity was enriched from Chinese hamster ovary media leading to the identification of group XV lysosomal phospholipase A2 isomer X1 (LPLA2) by shotgun proteomics. Recombinant LPLA2 was over expressed, purified, and functional integrity confirmed against a diheptanoyl phosphatidylcholine substrate. Incubation of recombinantly produced LPLA2 with PS20 and PS80 resulted in hydrolysis of PS20 and PS80 monoester but a much slower rate was observed for higher-order PS80. Endogenous LPLA2 was detected and quantitated at less than 1 ppm in 3 formulated antibodies while LPLA2 was not detected (or less than 0.1 ppm) in a fourth formulated antibody. Furthermore, antibodies with detectable quantities of endogenous LPLA2 demonstrated polysorbate hydrolysis while in contrast the antibody without detectable LPLA2 did not show polysorbate hydrolysis. Comparison of polysorbate degradation products generated from the formulated antibody and samples of polysorbate incubated with recombinant LPLA2 resulted in similar elution profiles by liquid chromatography-mass spectrometry. These results suggest that LPLA2 may play a key role in polysorbate degradation in some antibody preparations.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPLC; enzyme; mass spectrometry; protein; stability; surfactants

Mesh:

Substances:

Year:  2016        PMID: 27056628     DOI: 10.1016/j.xphs.2016.02.022

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

Review 1.  Considerations for the Use of Polysorbates in Biopharmaceuticals.

Authors:  Michael T Jones; Hanns-Christian Mahler; Sandeep Yadav; Dilbir Bindra; Vincent Corvari; R Matthew Fesinmeyer; Kapil Gupta; Alexander M Harmon; Kenneth D Hinds; Atanas Koulov; Wei Liu; Kevin Maloney; John Wang; Ping Y Yeh; Satish K Singh
Journal:  Pharm Res       Date:  2018-05-24       Impact factor: 4.200

2.  A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation.

Authors:  Nidhi Doshi; Jamie Giddings; Lin Luis; Arthur Wu; Kyle Ritchie; Wenqiang Liu; Wayman Chan; Rosalynn Taing; Jeff Chu; Alavattam Sreedhara; Aadithya Kannan; Pervina Kei; Ian Shieh; Tobias Graf; Mark Hu
Journal:  Pharm Res       Date:  2021-03-12       Impact factor: 4.200

Review 3.  Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects.

Authors:  Christian Schöneich
Journal:  Pharm Res       Date:  2020-02-03       Impact factor: 4.200

4.  Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations.

Authors:  Josephine Chiu; Kristin N Valente; Nicholas E Levy; Lie Min; Abraham M Lenhoff; Kelvin H Lee
Journal:  Biotechnol Bioeng       Date:  2016-12-27       Impact factor: 4.530

5.  Proteomic Analysis of Host Cell Protein Dynamics in the Culture Supernatants of Antibody-Producing CHO Cells.

Authors:  Jin Hyoung Park; Jong Hwa Jin; Myung Sin Lim; Hyun Joo An; Jong Won Kim; Gyun Min Lee
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

Review 6.  The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation.

Authors:  Xuanwen Li; Fengqiang Wang; Hong Li; Douglas D Richardson; David J Roush
Journal:  Antib Ther       Date:  2022-01-15

7.  Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product.

Authors:  Xuanwen Li; Yan An; Jing Liao; Li Xiao; Michael Swanson; Kirby Martinez-Fonts; Jorge Alexander Pavon; Edward C Sherer; Vibha Jawa; Fengqiang Wang; Xinliu Gao; Simon Letarte; Douglas D Richardson
Journal:  Biotechnol Prog       Date:  2021-03-12

8.  Exploring sample preparation and data evaluation strategies for enhanced identification of host cell proteins in drug products of therapeutic antibodies and Fc-fusion proteins.

Authors:  Wolfgang Esser-Skala; Marius Segl; Therese Wohlschlager; Veronika Reisinger; Johann Holzmann; Christian G Huber
Journal:  Anal Bioanal Chem       Date:  2020-07-20       Impact factor: 4.142

9.  Improving the analytical toolbox to investigate copurifying host cell proteins presence: N-(4)-(β-acetylglucosaminyl)- l-asparaginase case study.

Authors:  Séverine Clavier; Delphine Fougeron; Suzana Petrovic; Hagit Elmaleh; Céline Fourneaux; Dawid Bugnazet; Francis Duffieux; Alessandro Masiero; Shibani Mitra-Kaushik; Bruno Genet; Yann Fromentin; Patrick Kreiss; Bénédicte Laborderie; Dominique Brault; Jean-Michel Menet
Journal:  Biotechnol Bioeng       Date:  2020-08-03       Impact factor: 4.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.